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Abstract
During mitosis, the genome duplicated during S-phase is synchronously and accurately segregated
to the two daughter cells. The spindle checkpoint prevents premature sister-chromatid separation
and mitotic exit. The anaphase-promoting complex/cyclosome (APC/C) is a key target of the
spindle checkpoint. Upon checkpoint activation, the mitotic checkpoint complex (MCC) containing
Mad2, Bub3, Mad3/BubR1 and Cdc20 inhibits APC/C. Two independent studies in budding yeast
have now shed light on the mechanism by which MCC inhibits APC/C. These studies indicate that
Mad3 binds to the mitotic activator of APC/C Cdc20 using peptide motifs commonly found in APC/
C substrates and thus competes with APC/C substrates for APC/CCdc20 binding. In addition, Mad3
binding to APC/CCdc20 induces Cdc20 ubiquitination by APC/C, leading to the dissociation of MCC.
Meanwhile, two other studies have shown that a deubiquitinating enzyme is required for the spindle
checkpoint whereas APC/C-dependent ubiquitination is needed for checkpoint inactivation.
Collectively, these studies suggest a dynamic model for APC/CCdc20 regulation by MCC in which
APC/C- and Mad3-dependent ubiquitination of Cdc20 constitutes a self-regulated switch that
rapidly inactivates the spindle checkpoint upon correct chromosome attachment.
Background
Accurate chromosome segregation is the key event of
mitosis. Errors in this process result in aneuploidy and
genome instability, which contributes to cancer progres-
sion [1-4]. Mitotic chromosomes consist of pairs of sister
chromatids that separate at the onset of anaphase. Sister-
chromatid cohesion keeps sister chromatids together
from the very moment of chromosome duplication until
their separation. At metaphase, sister kinetochores are
attached to microtubules emanating from opposite poles,
a process referred to as amphitelic attachment or bi-orien-
tation. A multisubunit ubiquitin ligase called the ana-
phase-promoting complex or cyclosome (APC/C) in
conjunction with its mitotic activator Cdc20 then medi-
ates the degradation of cyclin B and securin, allowing the
activation of separase, cleavage of cohesin, and equal par-
tition of sister chromatids into the two daughter cells
[5,6]. Because microtubule attachment to kinetochores
occurs stochastically, improper kinetochore-microtubule
attachments, such as syntelic (sister kinetochores attach to
microtubules from the same pole), monotelic (only one
sister kinetochore attached), and merotelic attachments (a
kinetochore attaches to microtubules from both poles),
can form during mitosis [7,8]. These improper attach-
ments ought to be corrected prior to sister-chromatid sep-
aration. Cells use a control mechanism termed the spindle
checkpoint to ensure that all chromosomes are properly
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attached before initiating chromosome segregation
[9,10].
The spindle checkpoint monitors kinetochore-microtu-
bule attachment and possibly inter-kinetochore tension
generated by amphitelic attachments [11,12]. The unat-
tached kinetochores are thought to produce diffusible
checkpoint signals that inhibit APC/CCdc20 and block sis-
ter-chromatid separation [13,14]. An important check-
point inhibitor of APC/C is the mitotic checkpoint
complex that contains Mad2, Cdc20, Bub3 and BubR1
(Mad3 in budding yeast) [15], although it is presently
unclear whether MCC constitutes the diffusible check-
point signal and whether MCC only forms at the kineto-
chores [16-19]. Here, we review recent advances in our
understanding of APC/C regulation by the mitotic check-
point complex.
APC/C Regulation
APC/C is the only known molecular target of the spindle
checkpoint, although there is evidence to suggest that
other checkpoint targets might exist [20,21]. APC/C-
mediated ubiquitination leads to the degradation of cyc-
lin B and securin [5,21,22], allowing efficient sister chro-
matid separation and mitotic exit. The spindle checkpoint
inhibits APC/C and prevents sister-chromatid separation
and mitotic exit until all sister chormatids achieve bi-ori-
entation [3,21-25].
In addition to its involvement in anaphase onset and
mitotic exit, APC/C regulates other cell cycle events, such
as the G1/S transition [26,27] and initiation of DNA rep-
lication [28,29]. A growing number of APC/C regulators
are required for the precise regulation of APC/C activity
during different phases of the cell cycle [5,30-32]. These
APC/C regulators can be divided into three categories: (i)
APC/C activators, such as Cdc20 and Cdh1, which con-
tribute to substrate recognition and specificity of APC/C
[33-39]. (ii) Enzymatic regulators that post-translation-
ally modify core APC/C subunits or its activators [31,40-
48]. (iii) APC/C inhibitors, such as MCC [15,49,50] and
Emi1 [51,52] that regulate APC/C through direct binding
to APC/C or Cdc20 or both.
MCC, a key checkpoint inhibitor of APC/CCdc20
The first identified checkpoint inhibitor of APC/C was
Mad2 [53], which inhibits APC/C through direct binding
to Cdc20 [54,55]. The Mad2-Cdc20 interaction is
increased during mitosis, when the spindle checkpoint is
active [54,56,57]. However, checkpoint inhibition of
APC/CCdc20 turned out to be complex, involving more
than the simple Mad2-Cdc20 interaction. In addition to
Mad2, Mad3/BubR1-Bub3 binds to Cdc20 directly and
inhibits APC/C. Furthermore, Bub1-Bub3 directly phos-
phorylates Cdc20 and inhibits APC/CCdc20. Although
Mad2 and Mad3/BubR1 can inhibit APC/CCdc20  inde-
pendently, Mad3/BubR1 potentiates the ability of Mad2
to inhibit Cdc20 [50] and MCC containing BubR1/Mad3,
Bub3, Mad2 and Cdc20 inhibits APC/CCdc20 much more
effectively than of Mad2 alone [15]. Furthermore, it has
been recently shown that a complex containing Cdc20,
BubR1/Mad3 and Mad2 accounts for most of the APC/C
inhibitory activity in nocodazole-arrested HeLa cells [58].
Together, these results indicate that MCC is a major check-
point inhibitor of APC/C. Nonetheless, the existence of
MCC sub-complexes indicates that APC/CCdc20 inhibition
by Mad2 and BubR1/Mad3 involves multiple, complex
interactions.
How does MCC inhibit APC/CCdc20?
Because Cdc20 activates the ubiquitin ligase activity of
APC/C at least partially through substrate recruitment
[36,37,59], it was proposed that MCC interfered with
APC/CCdc20 function by either blocking the access of sub-
strates to Cdc20 or preventing the release of ubiquitinated
substrates. Recent studies in budding yeast provide key
insights into the mechanism by which MCC inhibits APC/
C and establish that the MCC subunit Mad3 (BubR1 in
humans) blocks substrate access to APC/CCdc20 [60,61].
Many APC/C substrates contain short peptide motifs that
mediate binding to and ubiquitination by APC/C, includ-
ing the destruction box (D box) and the KEN box. Two
groups have independently discovered that the budding
yeast Mad3 protein contains one D box and two KEN
boxes (Figure 1A) and that these degradation motifs of
Mad3 are required for its spindle checkpoint function
[60,61]. Furthermore, mutation of the N-terminal KEN
box of Mad3 dramatically reduced the association of
Mad3 with Cdc20 and Mad2 in vivo [61], indicating that
the Mad3 KEN boxes are required for MCC formation.
Although Mad3 binds directly to Cdc20 [60], this binding
requires Mad2 in vivo [60,61]. Addition of Mad2 increases
the Mad3-Cdc20 interaction about 4-fold in vitro [60].
How Mad2 stimulates Mad3 binding to Cdc20 remains
unclear. Mad2 binding could conceivably alter the confor-
mation of Cdc20, allowing more efficient Mad3 binding.
Because mutation of the N-terminal KEN box of Mad3
only reduced, but did not abolish, the Mad3-Cdc20 inter-
action, Burton and Solomon reasoned that other motifs of
Mad3 ought to be involved in Cdc20 binding. Using an in
vitro peptide competition assay, they determined that the
KEN- and D-boxes of Mad3 bind to Cdc20 cooperatively.
Furthermore, using the same assay, they showed that
Mad3 competes with known Cdc20 substrates for Cdc20
binding, and this ability of Mad3 depends on its D- and
KEN-boxes [60]. Taken together, these results indicate that
Mad3 inhibits APC/C by blocking substrate binding to
APC/CCdc20.Cell Division 2007, 2:23 http://www.celldiv.com/content/2/1/23
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Several non-exclusive models can explain the cooperative
binding of KEN and D boxes of Mad3 to Cdc20 (Figure
1B). In the monovalency model, multiple APC/C degrada-
tion motifs of Mad3 simultaneously bind to a single sub-
strate-binding site of Cdc20, thus blocking substrate-
binding by Cdc20. In the multivalency model, Cdc20 con-
tains multiple substrate-binding sites. Cooperative bind-
ing of multiple KEN and D boxes of Mad3 to these sites
blocks substrate binding by Cdc20. Finally, in the shared-
binding model, Mad3 inhibits APC/CCdc20 by binding to
both Cdc20 and APC/C. This model takes into account
the finding that APC/C can directly bind to destruction
motifs [62,63]. Simultaneous binding of Mad3 to APC/C
and Cdc20 would explain why mutations in the C-termi-
nal KEN box of Mad3 have little effect on Mad3-Cdc20
binding and yet this KEN box is still required for the spin-
dle checkpoint function of Mad3. High-resolution struc-
tural studies are required to understand the exact mode of
interactions between Mad3 and Cdc20.
Cdc20 ubiquitination and MCC disassembly
In addition to inhibiting APC/CCdc20 by blocking substrate
recruitment, Mad3 also destabilizes Cdc20 in a spindle
checkpoint-dependent manner [64]. King et al. demon-
strated that destabilization of Cdc20 requires the destruc-
tion motifs of Mad3 [61]. It has been recently shown that
Cdc20 is ubiquitinated by APC/C when the spindle check-
point is active [65,66]. Interestingly, Mad3 is unstable in
G1 whereas it is stable in nocodazole-treated cells [61].
These results suggest the intriguing possibility that Mad3
binding to Cdc20 directs APC/C activity towards Cdc20,
perhaps by mimicking substrate binding. Cdc20 ubiquiti-
nation leads to its proteasome-dependent degradation,
ensuring that Cdc20 levels are kept below a certain thresh-
old to prevent unscheduled APC/C activation [67].
Two recent studies have shown that degradation of Cdc20
is not the only outcome of Cdc20 ubiquitination [65,66].
Reddy  et al. have shown that Cdc20 ubiquitination
decreases its binding to Mad2 and to APC/C [66]. Cdc20
dissociation from Mad2 and APC/C does not require the
proteasome activity and Cdc20 degradation, as proteas-
ome inhibitors did not block this dissociation. Further-
more, addition of the ubiquitin-conjugating enzyme
UbcH10, but not its catalytically inactive mutant
UbcH10C114S, increases both Cdc20 ubiquitination and
the dissociation of Cdc20 from Mad2 and APC/C. Con-
versely, depletion of UbcH10 from HeLa cells decreases
APC/C-mediated ubiquitination of Cdc20, stabilizes the
Mad2-Cdc20 interaction, and delays anaphase initiation.
This study thus establishes that Cdc20 ubiquitination by
APC/C is required for checkpoint inactivation and con-
tributes to the dissociation of Cdc20 from Mad2 and pos-
sibly the disassembly of MCC[66]. In an accompanying
study, Steigmeier et al. have identified the ubiquitin-spe-
cific protease USP44 as a spindle checkpoint component
through an RNA interference (RNAi) screen [65,66].
Human cells depleted for USP44 by RNAi do not undergo
mitotic arrest in the presence of spindle poisons. The
checkpoint bypass of USP44 RNAi cells depends on APC/
C, although Mad2 and BubR1 (Mad3) localize normally
to kinetochores. Thus, USP44 acts downstream of Mad2
in APC/C inhibition. Furthermore, USP44 antagonizes
APC/C-mediated ubiquitination of Cdc20 in vivo. Recom-
binant USP44 directly deubiquitinates Cdc20 in vitro [65].
This study indicates that USP44 reduces Cdc20 autoubiq-
uitination and protects the Mad2-Cdc20-containing
checkpoint complexes from disassembly, although it
remains to be determined whether USP44 also directly
deubiquitinates mitotic APC/C substrates and prevents
their degradation.
The MCC paradox: inhibition through 
activation?
These recent studies establish that, similar to APC/C sub-
strates, Mad3 uses its APC/C degradation motifs to bind to
Cdc20, thus blocking substrate binding to APC/CCdc20.
Paradoxically, Mad3 binding to Cdc20 also activates the
autoubiquitination of Cdc20, which has at least two func-
tions: dissociation of Cdc20 from Mad2 and Cdc20 degra-
dation by the proteasome. Thus, Mad3 binding to Cdc20
would trigger the dissociation of Cdc20 from Mad2. We
Mad3 and its interaction with Cdc20 Figure 1
Mad3 and its interaction with Cdc20. A. Schematic 
drawing of Saccharomyces cerevisiae Mad3 (homolog of human 
BubR1). Mad3 contains several APC/C degradation motifs: a 
destruction box (D box) and two KEN boxes. B. Three pos-
sible mechanisms of Mad3 binding to Cdc20. The monova-
lency model proposes the cooperative binding of multiple 
motifs into a single docking site in Cdc20. The multivalency 
model proposes that the multiple degradation motifs of Mad3 
bind to different docking sites in Cdc20. In the shared-bind-
ing model, the degradation motifs of Mad3 bind to different 
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propose a "dynamic MCC" model to reconcile these find-
ings (Figure 2A). In this model, APC/C inhibition by the
spindle checkpoint is achieved through a regulated,
dynamic equilibrium of Cdc20 ubiquitination and deu-
biquitination. Checkpoint activation inhibits APC/CCdc20
by enhancing the formation of MCC and possibly its asso-
ciation with APC/C. Mad3 blocks access of substrates to
APC/CCdc20 and simultaneously induces Cdc20 ubiquiti-
nation. In human cells, Cdc20 ubiquitination is stimu-
lated by UbcH10 and possibly p31comet and is reversed by
USP44. Cdc20 ubiquitination leads to Cdc20 dissociation
from both APC/C and MCC components. Ubiquitinated
Cdc20 is either degraded by the proteasome or deubiqui-
tinated by USP44. If the spindle checkpoint stays on,
MCC can re-assemble and bind to and inhibit the APC/C
activity toward other substrates. Upon the proper attach-
ment of the last chromosome to the mitotic spindle, the
existing MCC can be rapidly disassembled through MCC-
and APC/C-dependent ubiquitination of Cdc20, leading
to checkpoint inactivation.
The steady state levels of MCC are determined by the rates
of MCC formation and disassembly. Three possible sce-
narios can explain the higher concentrations of MCC in
mitosis. First, the rate of MCC formation increases during
mitosis whereas the rate of MCC disassembly remains
constant during the cell cycle. Second, an increase in the
rate of MCC formation during mitosis is accompanied by
a concomitant drop in the rate of MCC disassembly. The
"dynamic MCC" model predicts a third scenario of MCC
regulation, in which both rates of MCC formation and
disassembly increase during mitosis (Figure 2B). By being
dynamic, the levels of MCC are more responsive to the
status of checkpoint signaling. Once the sister chromatids
achieve proper attachment, MCC can be quickly inacti-
vated to allow for APC/C activation and sister-chromatid
separation. In contrast, the first two scenarios predict a
slower and undesirable process of MCC inactivation and
checkpoint silencing.
Perspective
Recent discoveries establish a mechanism for Mad3-
dependent inhibition of APC/CCdc20 and reveal the func-
tion and regulation of a dynamic Cdc20 ubiquitination/
deubiquitination cycle during mitosis. These studies sup-
port a "dynamic MCC" model for maintaining a robust
spindle checkpoint and for the mechanistic coupling
between APC/C inhibition and checkpoint inactivation.
Many questions remain unresolved: does BubR1 (the ver-
tebrate ortholog of Mad3) bind to Cdc20 and inhibit
APC/CCdc20 using a mechanism similar to Mad3? Is USP44
conserved in other organisms? Is the activity of USP44 reg-
ulated by the spindle checkpoint? How are degradation of
Cdc20 and its deubiquitination by USP44 coordinated?
Future research aimed at addressing these questions will
A dynamic model for MCC-mediated inhibition of APC/C Figure 2
A dynamic model for MCC-mediated inhibition of 
APC/C. A. Mad3 uses its APC/C degradation motifs to bind 
to Cdc20 and blocks substrate binding of APC/CCdc20. Mean-
while, Mad3 binding to Cdc20 induces APC/C-dependent 
ubiquitination of Cdc20, which is antagonized by USP44. 
Ubiquitination of Cdc20 promotes the disassembly of MCC. 
Ubiquitinated Cdc20 is either degraded by the proteasome 
to reduce the cellular levels of Cdc20 or deubiquitinated by 
USP44. The deubiquitinated Cdc20 can be re-incorporated 
into MCC and associate with APC/C. Thus, upon checkpoint 
activation, a dynamic equilibrium of MCC formation and dis-
assembly is achieved by the continuous cycles of ubiquitina-
tion and deubiquitination of Cdc20. This process directs the 
activity of APC/C towards Cdc20 and reduces its activity 
towards cyclin B and securin. B. Schematic drawing of the 
rates of MCC formation and disassembly during mitosis. 
Upon checkpoint activation, Mad3 binds to Cdc20 and inhib-
its APC/C, but Mad3 binding also induces Cdc20 ubiquitina-
tion and the disassembly of MCC. Thus, the rates of MCC 
formation and disassembly may both be enhanced during 
active spindle checkpoint signaling. An equilibrium is reached 
to keep the steady-state levels of MCC constant, analogous 
to a runner on a treadmill. This model is also consistent with 
the finding that, at any given time, only small pools of the 
Mad2, Cdc20, Bub3 and Mad3 molecules in a cell associate 
with APC/C. Once all sister chromatids achieve bi-orienta-
tion, the rate of MCC formation falls below that of MCC dis-
assembly. The existing MCC complexes are rapidly 
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further advance the molecular understanding of the spin-
dle checkpoint.
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